Conventional, High-Intensity Laser, and Magnetic Field Therapies in Carpal Tunnel Syndrome

NCT07709156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2026-07-16

No results posted yet for this study

Summary

This retrospective study aims to compare the clinical effectiveness of conventional physical therapy, high-intensity laser therapy (HILT), and pulsed magnetic field therapy (PMFT) in individuals with carpal tunnel syndrome (CTS). The study evaluates changes in pain, symptom severity, functional status, hand grip strength, and electrophysiological findings following treatment. Researchers will compare the outcomes of the three treatment approaches to determine whether HILT or PMFT provides additional clinical benefits beyond conventional therapy. The findings may help clinicians select the most appropriate conservative treatment strategy for patients with CTS.

Conditions

  • Carpal Tunnel Syndrome (CTS)

Interventions

OTHER

Conventional Physical Therapy

A standardized conservative treatment program including therapeutic ultrasound, TENS, nerve and tendon gliding exercises, and neutral wrist splinting.

OTHER

High-Intensity Laser Therapy (HILT)

High-intensity laser therapy was applied according to the standard treatment protocol as an adjunct to conventional physical therapy.

OTHER

Pulsed Magnetic Field Therapy (PMFT)

Pulsed magnetic field therapy was applied according to the standard treatment protocol as an adjunct to conventional physical therapy.

Sponsors & Collaborators

  • KTO Karatay University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-20
Primary Completion
2024-10-20
Completion
2025-10-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07709156 on ClinicalTrials.gov